The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pH.
作者信息
Singh Sanjay K, Hammond David J, Beeler Bradley W, Agrawal Alok
出版信息
Clin Chim Acta. 2009 Nov;409(1-2):143-4. doi: 10.1016/j.cca.2009.08.013. Epub 2009 Aug 28.
Abstract
摘要
相似文献
1
The binding of C-reactive protein, in the presence of phosphoethanolamine, to low-density lipoproteins is due to phosphoethanolamine-generated acidic pH.
Clin Chim Acta. 2009 Nov;409(1-2):143-4. doi: 10.1016/j.cca.2009.08.013. Epub 2009 Aug 28.
2
Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.
Clin Chim Acta. 2009 Aug;406(1-2):151-5. doi: 10.1016/j.cca.2009.06.018. Epub 2009 Jun 21.
3
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells.
J Immunol. 2008 Mar 15;180(6):4316-22. doi: 10.4049/jimmunol.180.6.4316.
4
Exposing a hidden functional site of C-reactive protein by site-directed mutagenesis.
J Biol Chem. 2012 Jan 27;287(5):3550-8. doi: 10.1074/jbc.M111.310011. Epub 2011 Dec 9.
5
Identification of acidic pH-dependent ligands of pentameric C-reactive protein.
J Biol Chem. 2010 Nov 12;285(46):36235-44. doi: 10.1074/jbc.M110.142026. Epub 2010 Sep 14.
6
Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum.
Clin Chim Acta. 2008 Aug;394(1-2):94-8. doi: 10.1016/j.cca.2008.04.015. Epub 2008 Apr 27.
7
C-reactive protein: binding to lipids and lipoproteins.
Int Rev Exp Pathol. 1985;27:83-111.
8
Interactions of C-reactive protein with low-density lipoproteins: implications for an active role of modified C-reactive protein in atherosclerosis.
Int J Biochem Cell Biol. 2006;38(4):648-61. doi: 10.1016/j.biocel.2005.11.004. Epub 2005 Dec 7.
9
Binding of low density lipoprotein (LDL) to C-reactive protein (CRP): a possible binding through apolipoprotein B in LDL at phosphorylcholine-binding site of CRP.
Hokkaido Igaku Zasshi. 1990 Sep;65(5):474-80.
10
Iron released from transferrin at acidic pH can catalyse the oxidation of low density lipoprotein.
FEBS Lett. 1994 Sep 19;352(1):15-8. doi: 10.1016/0014-5793(94)00903-1.
引用本文的文献
1
Protection against prolonged pneumococcal infection involves structural changes in C-reactive protein and subsequent binding to both phosphocholine and amyloids on the bacterial surface.
Front Immunol. 2025 Jul 16;16:1631409. doi: 10.3389/fimmu.2025.1631409. eCollection 2025.
2
C-reactive protein: the nexus between inflammation and protein misfolding diseases.
Front Immunol. 2025 Jun 4;16:1612703. doi: 10.3389/fimmu.2025.1612703. eCollection 2025.
3
An evolutionarily conserved function of C-reactive protein is to prevent the formation of amyloid fibrils.
Front Immunol. 2024 Sep 16;15:1466865. doi: 10.3389/fimmu.2024.1466865. eCollection 2024.
4
A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein.
EMBO Mol Med. 2023 Jan 11;15(1):e16236. doi: 10.15252/emmm.202216236. Epub 2022 Dec 5.
5
Structurally Altered, Not Wild-Type, Pentameric C-Reactive Protein Inhibits Formation of Amyloid-β Fibrils.
J Immunol. 2022 Sep 15;209(6):1180-1188. doi: 10.4049/jimmunol.2200148. Epub 2022 Aug 17.
6
Functionality of C-Reactive Protein for Atheroprotection.
Front Immunol. 2019 Jul 16;10:1655. doi: 10.3389/fimmu.2019.01655. eCollection 2019.
7
Human Pentraxins Bind to Misfolded Proteins and Inhibit Production of Type I Interferon Induced by Nucleic Acid-Containing Amyloid.
J Clin Cell Immunol. 2015;6(3). doi: 10.4172/2155-9899.1000332. Epub 2015 Jun 23.
8
Functional Transformation of C-reactive Protein by Hydrogen Peroxide.
J Biol Chem. 2017 Feb 24;292(8):3129-3136. doi: 10.1074/jbc.M116.773176. Epub 2017 Jan 17.
9
C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation.
Int Sch Res Notices. 2014 Dec 15;2014:653045. doi: 10.1155/2014/653045. eCollection 2014.
10
Recognition functions of pentameric C-reactive protein in cardiovascular disease.
Mediators Inflamm. 2014;2014:319215. doi: 10.1155/2014/319215. Epub 2014 May 19.
本文引用的文献
1
Binding of the monomeric form of C-reactive protein to enzymatically-modified low-density lipoprotein: effects of phosphoethanolamine.
Clin Chim Acta. 2009 Aug;406(1-2):151-5. doi: 10.1016/j.cca.2009.06.018. Epub 2009 Jun 21.
2
Phosphoethanolamine-complexed C-reactive protein: a pharmacological-like macromolecule that binds to native low-density lipoprotein in human serum.
Clin Chim Acta. 2008 Aug;394(1-2):94-8. doi: 10.1016/j.cca.2008.04.015. Epub 2008 Apr 27.
3
C-reactive protein-bound enzymatically modified low-density lipoprotein does not transform macrophages into foam cells.
J Immunol. 2008 Mar 15;180(6):4316-22. doi: 10.4049/jimmunol.180.6.4316.
Zotero 插件